See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Amazon
Artificial Intelligence
Natural Disasters
Floods
Donald Trump
Social Media
Taxes
Education
Crime
Infrastructure
Republican Party
Cricket
Published • loading... • Updated

Long-Term Ixekizumab Treatment Does Not Raise Risk for Cancer in Patients With Chronic Inflammatory Disease

Summary by Medscape
Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, and axSpA, according to a pooled analysis of randomized trials.

1 Articles

All
Left
Center
Right
MedscapeMedscape

Long-Term Ixekizumab Treatment Does Not Raise Risk for Cancer in Patients With Chronic Inflammatory Disease

Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, and axSpA, according to a pooled analysis of randomized trials.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Wednesday, July 9, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer icon

Cancer

Medical icon

Medical

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal